Comparison of docetaxel/cisplatin dosages of 75/60 and 60/60 mg/m(2) for the treatment of non-small cell lung cancer

A combination of docetaxel (D) and cisplatin (P) is one of the standard regimens for the initial treatment of advanced non-small cell lung cancer (NSCLC). Yet, the toxicity of D administered at 75 mg/m(2) in three weekly doses to patients is a concern. The aim of this study was to assess the efficac...

Full description

Saved in:
Bibliographic Details
Main Authors: KIM, KYU-SIK, OH, IN-JAE, BAN, HEE-JUNG, CHO, HYUN-JU, KWON, YONG-SOO, KIM, YU-IL, LIM, SUNG-CHUL, NA, KOOK-JOO, SONG, SANG-YUN, CHOI, SONG, CHOI, YOO-DUK, KIM, YOUNG-CHUL
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2012
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3460243/
https://ncbi.nlm.nih.gov/pubmed/23139720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2012.597
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items